Expanding Cancer Screening With Multi-Cancer Early Detection
Sarah Enslin, PA-C, MS
In this four-part educational series, PA Sarah Enslin explores multi-cancer early detection (MCED) testing, a new technology that allows clinicians to screen for more than 50 types of cancer through a single blood draw.
The series covers why early detection matters, who’s an appropriate candidate, how the tests work, and how to guide patients through results and follow-up care. You will gain practical strategies for integrating MCED alongside established screening protocols and engaging patients in shared decision-making around cancer screening.
Video 1: The Value of Early Cancer Detection
Learn why early cancer detection matters and how to identify patients who may benefit from multi-cancer early detection testing.
Video 2: How Multi-Cancer Early Detection Tests Work
Understand how multi-cancer early detection tests work, what their results mean, and how they fit alongside established screening recommendations.
Video 3: Shared Decision-Making for Multi-Cancer Early Detection
Explore how to engage patients in shared decision-making around multi-cancer early detection, including addressing screening anxiety and personal preferences.
Video 4: Clinical Management Following Multi-Cancer Early Detection Testing
Follow a patient case to see how a positive multi-cancer early detection result translates into a targeted, collaborative follow-up plan.
Supported by
